HNGE - Entering Its Next Phase of Growth; Investor Day Takeaways

Research evidence excerpt

HNGE - Entering Its Next Phase of Growth; Investor Day Takeaways

ets Show Confidence in both Growth and Profitability. HNGE is aiming

for 20-25%+ revenue growth with 35%+ operating margins over time. Importantly, this Market Cap ($M) $5,113

outlook does not depend on raising prices. Instead, growth is expected to come from adding ADTV 909,293 more covered lives, improving engagement, and increasing how many members actively

Shares Out (M) 82 use the platform.

Short Interest Ratio/% Of Float 25.6%

Dividend/Yield $0.00/0.0% HingeSelect's Expansion Into Surgery Represents a Major Step Forward in Strategy.

With the rollout of surgery, Hinge now expands beyond digital care into coordinating in- Enterprise Value ($M) $4,908

person services like specialist visits, imaging, and surgery. Early feedback has been very Cash & Equivalents ($M) $406

positive, with strong employer interest and encouraging clinical results, including lower use of

Total Debt ($M) $0 unnecessary imaging and surgeries. The company is building a curated network of providers

Preferred Equity ($M) $200 focused on quality and cost, rather than simply offering a broad list of options. The move into

surgery is especially important, as it targets the largest portion of MSK spending. Beyond

20 Page Document MSK, migraine was also flagged as the company’s first major expansion into a new category.

Early adoption there has also been strong. Over time, migraine is expected to increase

engagement on the platform and contribute to higher usage and revenue per member.

Reasons for this report HingeSelect Revenue Opportunity. Management laid out a detailed economic framework

✓ Analyst Day Takeaways for its HingeSelect offering. While initial adoption is running ahead of expectations,